Bonduelle : Comeback of a rising trend?
Entry price | Target | Stop-loss | Potential |
---|
€19.58 |
€21.1 |
€19.18 |
+7.76% |
---|
Shares in Bonduelle reflect an interesting technical chart pattern allowing for a bet on a reversal of the medium term trend.
Summary● The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths● The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
● The company shows low valuation levels, with an enterprise value at 0.44 times its sales.
● The company appears to be poorly valued given its net asset value.
● Given the positive cash flows generated by its business, the company's valuation level is an asset.
● Analyst opinion has improved significantly over the past four months.
● There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Weaknesses● As estimated by analysts, this group is among those businesses with the lowest growth prospects.
● The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
● The company sustains low margins.
The content herein constitutes a general investment recommendation, prepared in accordance with provisions aimed at preventing market abuse by Surperformance, the publisher of MarketScreener.com. More specifically, this recommendation is based on factual elements and expresses a sincere, complete, and balanced opinion. It relies on internal or external data, considered reliable as of the date of their release. Nevertheless, this information, and the resulting recommendation, may contain inaccuracies, errors, or omissions, for which Surperformance cannot be held responsible. This recommendation, which in no way constitutes investment advice, may not be suitable for all investor profiles. The reader acknowledges and accepts that any investment in a financial instrument involves risks, for which they assume full responsibility, without recourse against Surperformance. Surperformance commits to disclosing any conflict of interest that may affect the objectivity of its recommendations.